The Japanese pharma is currently investigating mezagitamab’s potential in two late-stage autoimmune programmes.

PlateletDiagnostics, LLC (PlateletDx.com) today announced the development of a first-in-class platelet function assay that measures phosphorylation of the abundant platelet protein, dynamin-related ...

Mezagitamab is a fully human IgG1 monoclonal antibody that targets CD38, which is highly expressed on the surface of plasma ...

A collaborative study led by researchers at Baylor College of Medicine explores the effects of aspirin on a new biologic therapy, platelet rich plasma (PRP). This is the first study of its kind to ...

Introduction Antiphospholipid syndrome (APS) is an autoimmune disease characterised by obstetric morbidity and recurrent ...

Known as thrombocytopenia in medical terms, low platelet count is a health disorder in which your blood platelets are lower than normal. Platelets are the tiniest among the blood cells, much smaller ...

BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...

Please provide your email address to receive an email when new articles are posted on . Individuals with an increased platelet count demonstrated an increased risk for cancer, with the association ...

PlateletDiagnostics develops novel immune-based platelet function assay to monitor antiplatelet therapy: Watertown, Massachusetts Wednesday, April 8, 2026, 18:00 Hrs [IST] Platele ...